The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Wada, Takeshi ^a   Jesmin, Subrina ^a,b,c   Gando, Satoshi ^a   Yanagida, Yuichiro ^a   Mizugaki, Asumi ^d   Sultana, Sayeeda Nusrat ^c   Zaedi, Sohel ^c   Yokota, Hiroyuki ^d  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Probal Housing Ltd   (Bangladesh)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Angiogenic factors; Angiopoietin; Outcome; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; GROWTH FACTOR RECEPTOR; SOLUBLE ANGIOGENIC FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEART ARREST; HOSPITAL ADMISSION; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUT OF HOSPITAL CARDIAC ARREST; POST CARDIAC ARREST SYNDROME; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; RESUSCITATION; SEPSIS;

EID: 84873510243     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-6     Document Type: Article

References (41)

1. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, Am J Respir Crit Care Med 1994 149 818 824 7509706 (Pubitemid 24082248)
2. Acute respiratory distress syndrome: the Berlin definition. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS, JAMA 2012 307 2526 2533 22797452
3. Acute respiratory distress syndrome: pathophysiology and therapeutic options. Pierrakos C, Karanikolas M, Scolletta S, Karamouzos V, Velissaris D, J Clin Med Res 2012 4 7 16 22383921
4. The acute respiratory distress syndrome. Ware LB, Matthay MA, N Engl J Med 2000 342 1334 1349 10.1056/NEJM200005043421806 10793167 (Pubitemid 30408719)
5. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study. Yang KY, Liu KT, Chen YC, Chen CS, Lee YC, Perng RP, Feng JY, Crit Care 2011 15 11 10.1186/cc9412 21219633
6. Molecular and biological properties of vascular endothelial growth factor. Ferrara N, J Mol Med 1999 77 527 543 10.1007/s001099900019 10494799 (Pubitemid 29426311)
7. Bench-to-bedside review: Angiopoietin signalling in critical illness-a future target? van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG, Crit Care 2009 13 207 10.1186/cc7153 19435476
8. Angiopoietins: a link between angiogenesis and inflammation. Fiedler U, Augustin HG, Trends Immunol 2006 27 552 558 10.1016/j.it.2006.10.004 17045842 (Pubitemid 44780853)
9. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Ricciuto DR, Dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, et al. Crit Care Med 2011 39 702 710 10.1097/CCM.0b013e318206d285 21242795
10. Signaling and functions of angiopoietin-1 in vascular protection. Brindle NP, Saharinen P, Alitalo K, Circ Res 2006 98 1014 1023 10.1161/01.RES. 0000218275.54089.12 16645151
11. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Science 1997 277 55 60 10.1126/science.277.5322.55 9204896 (Pubitemid 27450643)
12. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Lobov IB, Brooks PC, Lang RA, Proc Natl Acad Sci USA 2002 99 11205 11210 10.1073/pnas.172161899 12163646 (Pubitemid 34920903)
13. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ganter MT, Cohen MJ, Brohi K, Chesebro BB, Staudenmayer KL, Rahn P, Christiaans SC, Bir ND, Pittet JF, Ann Surg 2008 247 320 326 10.1097/SLA.0b013e318162d616 18216540 (Pubitemid 351156777)
14. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Ong T, McClintock DE, Kallet RH, Ware LB, Matthay MA, Liu KD, Crit Care Med 2010 38 1845 1851 10.1097/CCM.0b013e3181eaa5bf 20581666
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992 20 864 874 10.1097/00003246-199206000-00025 1597042
16. The Abbreviated Injury Scale, 1985 revision: a condensed chart for clinical use. Civil ID, Schwab CW, J Trauma 1988 28 87 90 10.1097/00005373- 198801000-00012 3339667
17. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation: Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2000 102 Suppl I -380 I-384
18. Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe trauma. Wada T, Jesmin S, Gando S, Sultana SN, Zaedi S, Yokota H, Crit Care 2012 16 63 10.1186/cc11309 22520052
19. The Dynamics of Angiogenic Factors and Their Soluble Receptors in Relation to Organ Dysfunction in Disseminated Intravascular Coagulation Associated with Sepsis. Jesmin S, Wada T, Gando S, Sultana SS, Zaedi S, Inflammation 2012 36 186 196
20. Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome. Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, Zaedi S, Yokota H, Crit Care 2012 16 171 10.1186/cc11648 23021336
21. APACHE II: a severity of disease classification system. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, Crit Care Med 1985 13 818 829 10.1097/00003246- 198510000-00009 3928249 (Pubitemid 15250137)
22. Serial evaluation of the SOFA score to predict outcome in critically ill patients. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL, JAMA 2001 286 1754 1758 10.1001/jama.286.14.1754 11594901 (Pubitemid 33010262)
23. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000 342 1301 1308 10793162
24. Vascular endothelial growth factor and related molecules in acute lung injury. Mura M, dos Santos CC, Stewart D, Liu M, J Appl Physiol 2004 97 1605 1617 10.1152/japplphysiol.00202.2004 15475552 (Pubitemid 39425973)
25. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Mankhambo LA, Banda DL, Jeffers G, White SA, Balmer P, Nkhoma S, Phiri H, Molyneux EM, Hart CA, Molyneux ME, et al. Crit Care 2010 14 91 10.1186/cc9025 20492647
26. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC, Shock 2008 29 452 457 10.1097/SHK.0b013e31815072c1 18598002 (Pubitemid 351416810)
27. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE, Clin Sci (Lond) 1998 94 395 404 (Pubitemid 28176624)
28. Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1. Vidal F, Aragones J, Alfranca A, de Landazuri MO, Blood 2000 95 3387 3395 10828020 (Pubitemid 30428468)
29. Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study. Alves BE, Montalvao SA, Aranha FJ, Lorand-Metze I, De Souza CA, Annichino-Bizzacchi JM, De Paula EV, J Transl Med 2011 9 23 10.1186/1479-5876-9-23 21371321
30. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Takahashi H, Shibuya M, Clin Sci (Lond) 2005 109 227 241 10.1042/CS20040370 (Pubitemid 41337127)
31. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Medford AR, Millar AB, Thorax 2006 61 621 626 10.1136/thx.2005.040204 16807391 (Pubitemid 44035144)
32. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin. Terracciano C, Fiore S, Doldo E, Manzari V, Marfia GA, Bernardi G, Massa R, Albonici L, Muscle Nerve 2010 42 445 448 10.1002/mus.21718 20589895
33. Admission angiopoietin levels in children with septic shock. Giuliano JS Jr, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS, Shock 2007 28 650 654 18092380 (Pubitemid 350135468)
34. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, Crit Care Med 2012 40 1731 1737 10.1097/CCM.0b013e3182451c87 22610178
35. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT, Crit Care 2008 12 147 10.1186/cc7130 19025590
36. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C, Crit Care Med 2007 35 199 206 10.1097/01.CCM.0000251640.77679.D7 17110873 (Pubitemid 46035696)
37. Angiopoietin-1 protects the adult vasculature against plasma leakage. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD, Nat Med 2000 6 460 463 10.1038/74725 10742156 (Pubitemid 30208166)
38. Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis. Alfieri A, Watson JJ, Kammerer RA, Tasab M, Progias P, Reeves K, Brown NJ, Brookes ZL, Crit Care 2012 16 182 10.1186/cc11666 23036162
39. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Reusch P, Barleon B, Weindel K, Martiny-Baron G, Godde A, Siemeister G, Marme D, Angiogenesis 2001 4 123 131 10.1023/A:1012226627813 11806244 (Pubitemid 34032698)
40. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Findley CM, Cudmore MJ, Ahmed A, Kontos CD, Arterioscler Thromb Vasc Biol 2007 27 2619 2626 10.1161/ATVBAHA.107.150482 17901375 (Pubitemid 350158914)
41. The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients. van der Heijden M, van Nieuw Amerongen GP, van Hinsbergh VW, Groeneveld AB, Shock 2010 33 263 268 10.1097/SHK.0b013e3181b2f978 19543148